Size: px
Start display at page:

Download ""

Transcription

1

2

3

4

5

6

7

8

9

10

11

12

13 CLINICAL FEATURES THAT SUPPORT ATHEROSCLEROTIC STROKE 1. cerebral cortical impairment (aphasia, neglect, restricted motor involvement, etc.) or brain stem or cerebellar dysfunction 2. lacunar clinical presentation (e.g., pure motor hemiparesis or ataxic hemiparesis) is frequent in ATS stroke 3. TIAs in the same vascular territory, a carotid bruit, diminished pulses support a clinical diagnosis of ATS stroke 4. hypertension, chronic obstructive pulmonary disease, diabetes mellitus, hyperlipidemia are significantly associated with ATS stroke 5. sudden onset of neurological deficit are less frequent in ATS infarctions CLINICAL FEATURES THAT SUPPORT CARDIOEMBOLIC STROKE 1. clinical findings are similar to those described for large-artery atherosclerosis (but, more often: severe stroke, disability and death) 2. cardiac embolism is a very rare cause of lacunar infarction 3. previous TIA or stroke in more than one vascular territory or systemic embolism supports a clinical diagnosis of CE stroke 4. atrial fibrillation, recognition of an emboligenic heart disease are independently associated with CE stroke 5. sudden onset of neurological deficit and the rapid regression of symptoms are important for a clinical suspicion of the CE origin of stroke 6. altered consciousness is a predictive factor of CE cerebral infarction 7. no paradoxical embolism in ATS stroke 7. the onset of symptoms after a Valsalvaprovoking activity (coughing, bending, etc.) suggesting paradoxical embolism.

14

15

16

17

18

19

20 BIOMARKERS IN CARDIOEMBOLIC/ATHEROSCLEROTIC STROKE 1. at present there is no biologic marker offering precise information about stroke etiology 2. elevated plasma BNP/D-dimer levels can be a potential marker of the presence of left atrial sources of emboli in ischemic stroke pts. 3. BNP/D-dimer are strongly associated with CE stroke and functional outcome 4. the cut-off values of BNP/D-dimer need further validation

21

22

23

24

25

26

27 CT/MR FINDINGS THAT SUPPORT LA ATS STROKE INCLUDE: cortical or cerebellar lesions and brain stem or subcortical hemispheric infarcts > than 1.5 cm in diameter CT/MR FINDINGS THAT SUPPORT CE STROKE INCLUDE: brain imaging findings are similar to those described for large-artery atherosclerosis unique (more often) ischemic area simultaneous or sequential infarctions in differential arterial territories hemorrhagic transformation of infarction (more frequent in CE stroke)

28

29

30

31

32

33

34

35

36

37

38

39

40

41

42

43

44

45

46

47

48

49

50 ECG, TEE, TTE, TCD BUBBLE TEST FINDINGS THAT SUPPORT LA ATS STROKE INCLUDE: no CE sources of high and medium risk (no recognition of an emboligenic heart disease) ECG, TEE, TTE, TCD BUBBLE TEST FINDINGS THAT SUPPORT CE STROKE INCLUDE: ECG, 24-hour Holter ECG, 7-day ECG (AF and PAF diagnosis) TTE/TEE recognition of CE sources of high and medium risk TCD/TEE recognition of rt->lt large shunt in patient with cerebral infarction of unknown aetiology TEE recognition of plaque thickness 4 mm and mobile components in the aortic arch (pts in whom a cerebral infarctionattributable aetiology is not found)

51

52

53

54

55

56

57

58

59

60

61

62 ?

63

64

65

66

67 ?

68

69

70

71

72

73

74 US/NR FINDINGS THAT SUPPORT LA ATS STROKE INCLUDE: hemodynamic plaque in an intra/extracranial artery supplying the ischemic stroke occlusion with imaging evidence of atherosclerosis in an intra/extracranial artery supplying the ischemic stroke not hemodynamic plaque in an intra/extracranial artery supplying the ischemic field with attached luminal thrombus uniteral MES: suggestive of ATS stroke (TCD monitoring) US/NR FINDINGS THAT SUPPORT CE STROKE INCLUDE: occlusion of the carotid artery by mobile embolus early recanalisation of occluded extra/intracranial vessel simultaneous or sequential embolism in different arteries (extra/intracranial) bilateral MES: suggestive of CE stroke (TCD monitoring)

75

76

77 CARDIOEMBOLIC OR ATHEROSCLEROTIC STROKE? 1. medical history and physical exam; 2. extra-intracranial vessels imaging; 3. head CT±MRI; 4. ECG; 5. chest Rx

78 CARDIOEMBOLIC OR ATHEROSCLEROTIC STROKE? 1. medical history and physical exam; 2. extra-intracranial vessels imaging; 3. head CT±MRI; 4. ECG; 5. chest Rx DIAGNOSIS 1. CE stroke?; 2. ATS stroke? (with exclusion of other cause for the stroke)

79 CARDIOEMBOLIC OR ATHEROSCLEROTIC STROKE? 1. medical history and physical exam; 2. extra-intracranial vessels imaging; 3. head CT±MRI; 4. ECG; 5. chest Rx DIAGNOSIS 1. CE stroke?; 2. ATS stroke? (with exclusion of other cause for the stroke) 1. TTE 2. Holter ECG (24 h/7 days) cardiac source of embolism identified CARDIOEMBOLIC STROKE

80 CARDIOEMBOLIC OR ATHEROSCLEROTIC STROKE? 1. medical history and physical exam; 2. extra-intracranial vessels imaging; 3. head CT±MRI; 4. ECG; 5. chest Rx 1. TTE 2. Holter ECG (24 h/7 days) no cardiac source of embolism identified 1. TEE/TCD bubble test 2. TCD monitoring (bilateral MES) 3. vein ECD/angioCT (IVC, iliac veins) 4. biomarkers (?) cardiac source of embolism identified CARDIOEMBOLIC STROKE DIAGNOSIS 1. CE stroke?; 2. ATS stroke? (with exclusion of other cause for the stroke)

81 CARDIOEMBOLIC OR ATHEROSCLEROTIC STROKE? 1. medical history and physical exam; 2. extra-intracranial vessels imaging; 3. head CT±MRI; 4. ECG; 5. chest Rx 1. TTE 2. Holter ECG (24 h/7 days) no cardiac source of embolism identified DIAGNOSIS 1. CE stroke?; 2. ATS stroke? (with exclusion of other cause for the stroke) 1. TEE/TCD bubble test 2. TCD monitoring (bilateral MES) 3. vein ECD/angioCT (IVC, iliac veins) 4. biomarkers (?) no cardiac source of embolism identified ATS STROKE

82 short videos and playlists on echocolor Doppler of the extraintracranial vessels are available on my youtube channel:

/ / / / / / Hospital Abstraction: Stroke/TIA. Participant ID: Hospital Code: Multi-Ethnic Study of Atherosclerosis

/ / / / / / Hospital Abstraction: Stroke/TIA. Participant ID: Hospital Code: Multi-Ethnic Study of Atherosclerosis Multi-Ethnic Study of Atherosclerosis Participant ID: Hospital Code: Hospital Abstraction: Stroke/TIA History and Hospital Record 1. Was the participant hospitalized as an immediate consequence of this

More information

ACUTE CENTRAL PERIFERALEMBOLISM

ACUTE CENTRAL PERIFERALEMBOLISM EAE TEACHING COURSE 2010 Belgrade, Serbia October 22-23, 2010 ACUTE CENTRAL and PERIFERALEMBOLISM Maria João Andrade Lisbon, PT BACKGROUND Stroke is a leading cause of mortality and long-term disability

More information

Stroke/TIA. Tom Bedwell

Stroke/TIA. Tom Bedwell Stroke/TIA Tom Bedwell tab1g11@soton.ac.uk The Plan Definitions Anatomy Recap Aetiology Pathology Syndromes Brocas / Wernickes Investigations Management Prevention & Prognosis TIAs Key Definitions Transient

More information

[(PHY-3a) Initials of MD reviewing films] [(PHY-3b) Initials of 2 nd opinion MD]

[(PHY-3a) Initials of MD reviewing films] [(PHY-3b) Initials of 2 nd opinion MD] 2015 PHYSICIAN SIGN-OFF (1) STUDY NO (PHY-1) CASE, PER PHYSICIAN REVIEW 1=yes 2=no [strictly meets case definition] (PHY-1a) CASE, IN PHYSICIAN S OPINION 1=yes 2=no (PHY-2) (PHY-3) [based on all available

More information

Patent Foramen Ovale and Cryptogenic Stroke: Do We Finally Have Closure? Christopher Streib, MD, MS

Patent Foramen Ovale and Cryptogenic Stroke: Do We Finally Have Closure? Christopher Streib, MD, MS Patent Foramen Ovale and Cryptogenic Stroke: Do We Finally Have Closure? Christopher Streib, MD, MS 11-8-18 Outline 1. Background 2. Anatomy of patent foramen ovale (PFO) 3. Relationship between PFO and

More information

Management and Investigation of Ischemic Stroke By Etiology

Management and Investigation of Ischemic Stroke By Etiology Management and Investigation of Ischemic Stroke By Etiology Andrew M. Demchuk MD FRCPC Director, Calgary Stroke Program Deputy Dept Head, Clinical Neurosciences Heart and Stroke Foundation Chair in Stroke

More information

How to Evaluate Patients with Cryptogenic Stroke

How to Evaluate Patients with Cryptogenic Stroke How to Evaluate Patients with Cryptogenic Stroke Jeffrey Saver, MD Professor of Neurology Director, How to Evaluate Patients with Cryptogenic Stroke Disclosure Scientific Consultant, Unpaid Trialist: AGA

More information

Permanent foramen ovale: when to close?

Permanent foramen ovale: when to close? Permanent foramen ovale: when to close? Pierre Amarenco INSERM U-698 and Denis Diderot University - Paris VII Department of Neurology and Stroke Center Bichat hospital, Paris, France PFO - Pathology TEE

More information

PFO Management update

PFO Management update PFO Management update May 12, 2017 Peter Casterella, MD Swedish Heart and Vascular 1 PFO Update 2017: Objectives Review recently released late outcomes of RESPECT trial and subsequent FDA approval of PFO

More information

MEET 2007: Evaluation and treatment of the stroke and TIA patient for the non-neurointerventionist. neurointerventionist

MEET 2007: Evaluation and treatment of the stroke and TIA patient for the non-neurointerventionist. neurointerventionist MEET 2007: Evaluation and treatment of the stroke and TIA patient for the non-neurointerventionist neurointerventionist Steve Ramee, MD Ochsner Medical Center New Orleans DISCLOSURE Nothing Nothing to

More information

Acute stroke. Ischaemic stroke. Characteristics. Temporal classification. Clinical features. Interpretation of Emergency Head CT

Acute stroke. Ischaemic stroke. Characteristics. Temporal classification. Clinical features. Interpretation of Emergency Head CT Ischaemic stroke Characteristics Stroke is the third most common cause of death in the UK, and the leading cause of disability. 80% of strokes are ischaemic Large vessel occlusive atheromatous disease

More information

What the general cardiologist should know about arrhythmia Stroke prevention in AF" Peter Ammann Kantonsspital St. Gallen

What the general cardiologist should know about arrhythmia Stroke prevention in AF Peter Ammann Kantonsspital St. Gallen What the general cardiologist should know about arrhythmia Stroke prevention in AF" Peter Ammann Kantonsspital St. Gallen What the cardiologist should know about arrhythmia and stroke are there real low

More information

How Can We Properly Manage Patients With Stroke of Undetermined Origin?

How Can We Properly Manage Patients With Stroke of Undetermined Origin? How Can We Properly Manage Patients With Stroke of Undetermined Origin? : Spotlight on Embolic Stroke of Undetermined Source (ESUS) MI SUN OH Department of Neurology, Hallym University Scared Heart Hospital,

More information

Carotid Artery Revascularization: Current Strategies. Shonda Banegas, D.O. Vascular Surgery Carondelet Heart and Vascular Institute September 6, 2014

Carotid Artery Revascularization: Current Strategies. Shonda Banegas, D.O. Vascular Surgery Carondelet Heart and Vascular Institute September 6, 2014 Carotid Artery Revascularization: Current Strategies Shonda Banegas, D.O. Vascular Surgery Carondelet Heart and Vascular Institute September 6, 2014 Disclosures None 1 Stroke in 2014 Stroke kills almost

More information

Ischemic Stroke in Critically Ill Patients with Malignancy

Ischemic Stroke in Critically Ill Patients with Malignancy Ischemic Stroke in Critically Ill Patients with Malignancy Jeong-Am Ryu 1, Oh Young Bang 2, Daesang Lee 1, Jinkyeong Park 1, Jeong Hoon Yang 1, Gee Young Suh 1, Joongbum Cho 1, Chi Ryang Chung 1, Chi-Min

More information

Acute arterial embolism

Acute arterial embolism Acute arterial embolism Definition Thrombus come from heart or blood vessel or other embolus such as tumor,air gas or fat flow with blood stream and occlude distal limb or visceral arteries which causes

More information

Cryptogenic Strokes: Evaluation and Management

Cryptogenic Strokes: Evaluation and Management Cryptogenic Strokes: Evaluation and Management 77 yo man with hypertension and hyperlipidemia developed onset of left hemiparesis and right gaze preference, last seen normal at 10:00 AM Brought to ZSFG

More information

11/2/2016. Stroke. Carl F. McComas, M.D. November 3, Disclosures. None (of any kind)

11/2/2016. Stroke. Carl F. McComas, M.D. November 3, Disclosures. None (of any kind) Stroke Carl F. McComas, M.D. November 3, 2016 None (of any kind) Disclosures 1 HYPERTENSION Stroke The seat of apoplexy seems to be within the same portion of the of the brain.... Both affects, the imagination,

More information

Is Stroke a Paradoxical Embolism in Patients with Patent Foramen Ovale?

Is Stroke a Paradoxical Embolism in Patients with Patent Foramen Ovale? ORIGINAL ARTICLE Is Stroke a Paradoxical Embolism in Patients with Patent Foramen Ovale? Masahiro YASAKA, Ryoichi OTSUBO, Hiroshi OE and Kazuo MINEMATSU Abstract Objective Purpose was to assess the stroke

More information

Neuroanatomy of a Stroke. Joni Clark, MD Professor of Neurology Barrow Neurologic Institute

Neuroanatomy of a Stroke. Joni Clark, MD Professor of Neurology Barrow Neurologic Institute Neuroanatomy of a Stroke Joni Clark, MD Professor of Neurology Barrow Neurologic Institute No disclosures Stroke case presentations Review signs and symptoms Review pertinent exam findings Identify the

More information

Intended Learning Outcomes

Intended Learning Outcomes 2011 Acute Limb Ischemia Definition, Etiology & Pathophysiology Clinical Evaluation Management Ali SABBOUR Prof. of Vascular Surgery, Ain Shams University Acute Limb Ischemia Intended Learning Outcomes

More information

Cerebrovascular Disorders. Blood, Brain, and Energy. Blood Supply to the Brain 2/14/11

Cerebrovascular Disorders. Blood, Brain, and Energy. Blood Supply to the Brain 2/14/11 Cerebrovascular Disorders Blood, Brain, and Energy 20% of body s oxygen usage No oxygen/glucose reserves Hypoxia - reduced oxygen Anoxia - Absence of oxygen supply Cell death can occur in as little as

More information

Cryptogenic Stroke: A logical approach to a common clinical problem

Cryptogenic Stroke: A logical approach to a common clinical problem Cryptogenic Stroke: A logical approach to a common clinical problem Alphonse M. Ambrosia, DO, FACC Interventional Cardiologist CardioVascular Associates of Mesa Mesa, Arizona Speakers Bureau Boston Scientific

More information

Overview of Stroke: Etiologies, Demographics, Syndromes, and Outcomes. Alex Abou-Chebl, MD, FSVIN Medical Director, Stroke Baptist Health Louisville

Overview of Stroke: Etiologies, Demographics, Syndromes, and Outcomes. Alex Abou-Chebl, MD, FSVIN Medical Director, Stroke Baptist Health Louisville Overview of Stroke: Etiologies, Demographics, Syndromes, and Outcomes Alex Abou-Chebl, MD, FSVIN Medical Director, Stroke Baptist Health Louisville Disclosure Statement of Financial Interest Within the

More information

2017 Cardiovascular Symposium CRYPTOGENIC STROKE: A CARDIOVASCULAR PERSPECTIVE DR. WILLIAM DIXON AND DR. VENKATA BAVAKATI SOUTHERN MEDICAL GROUP, P.A.

2017 Cardiovascular Symposium CRYPTOGENIC STROKE: A CARDIOVASCULAR PERSPECTIVE DR. WILLIAM DIXON AND DR. VENKATA BAVAKATI SOUTHERN MEDICAL GROUP, P.A. CRYPTOGENIC STROKE: 2017 Cardiovascular Symposium A CARDIOVASCULAR PERSPECTIVE DR. WILLIAM DIXON AND DR. VENKATA BAVAKATI SOUTHERN MEDICAL GROUP, P.A. CRYPTOGENIC STROKE CRYPTOGENIC: OF OBSCURE OR UNKNOWN

More information

TIA: Updates and Management 2008

TIA: Updates and Management 2008 TIA: Updates and Management 2008 S. Andrew Josephson, MD Department of Neurology, Neurovascular Division University of California San Francisco Commonly Held TIA Misconceptions TIA is easy to diagnose

More information

Cerebral Vascular Diseases. Nabila Hamdi MD, PhD

Cerebral Vascular Diseases. Nabila Hamdi MD, PhD Cerebral Vascular Diseases Nabila Hamdi MD, PhD Outline I. Stroke statistics II. Cerebral circulation III. Clinical symptoms of stroke IV. Pathogenesis of cerebral infarcts (Stroke) 1. Ischemic - Thrombotic

More information

Antithrombotic therapy in patients with transient ischemic attack / stroke (acute phase <48h)

Antithrombotic therapy in patients with transient ischemic attack / stroke (acute phase <48h) Antithrombotic therapy in patients with transient ischemic attack / stroke (acute phase

More information

Advances in Prevention and Treatment of Stroke: What Every Primary Care Physician Needs to Know. Case 1 4/5/11. What treatment should you initiate?

Advances in Prevention and Treatment of Stroke: What Every Primary Care Physician Needs to Know. Case 1 4/5/11. What treatment should you initiate? Advances in Prevention and Treatment of Stroke: What Every Primary Care Physician Needs to Know S. Andrew Josephson, MD Director, Neurohospitalist Program Medical Director, Inpatient Neurology University

More information

MD SUBTYPE ADJUDICATION VARIABLE DEFINITIONS MANUAL The following is a list of variables and how to complete each one:

MD SUBTYPE ADJUDICATION VARIABLE DEFINITIONS MANUAL The following is a list of variables and how to complete each one: MD SUBTYPE ADJUDICATION VARIABLE DEFINITIONS MANUAL 2014-15 The following is a list of variables and how to complete each one: (PHY-1) Case, per physician review: The most important task for the physicians

More information

HEART AND SOUL STUDY OUTCOME EVENT - MORBIDITY REVIEW FORM

HEART AND SOUL STUDY OUTCOME EVENT - MORBIDITY REVIEW FORM REVIEW DATE REVIEWER'S ID HEART AND SOUL STUDY OUTCOME EVENT - MORBIDITY REVIEW FORM : DISCHARGE DATE: RECORDS FROM: Hospitalization ER Please check all that may apply: Myocardial Infarction Pages 2, 3,

More information

CT and MR Imaging in Young Stroke Patients

CT and MR Imaging in Young Stroke Patients CT and MR Imaging in Young Stroke Patients Ashfaq A. Razzaq,Behram A. Khan,Shahid Baig ( Department of Neurology, Aga Khan University Hospital, Karachi. ) Abstract Pages with reference to book, From 66

More information

Key Clinical Concepts

Key Clinical Concepts Cerebrovascular Review and General Vascular Syndromes, Including Those That Impact Dizziness Key Clinical Concepts Basic Review of Cerebrovascular Circulation Circulation to the brain is divided into anterior

More information

Cryptogenic Stroke: What Don t We Know. Siddharth Sehgal, MD Medical Director, TMH Stroke Center Tallahassee Memorial Healthcare

Cryptogenic Stroke: What Don t We Know. Siddharth Sehgal, MD Medical Director, TMH Stroke Center Tallahassee Memorial Healthcare Cryptogenic Stroke: What Don t We Know Siddharth Sehgal, MD Medical Director, TMH Stroke Center Tallahassee Memorial Healthcare Financial Disclosures None Objectives Principles of diagnostic evaluation

More information

CEREBRO VASCULAR ACCIDENTS

CEREBRO VASCULAR ACCIDENTS CEREBRO VASCULAR S MICHAEL OPONG-KUSI, DO MBA MORTON CLINIC, TULSA, OK, USA 8/9/2012 1 Cerebrovascular Accident Third Leading cause of deaths (USA) 750,000 strokes in USA per year. 150,000 deaths in USA

More information

The Impact of Smoking on Acute Ischemic Stroke

The Impact of Smoking on Acute Ischemic Stroke Smoking The Impact of Smoking on Acute Ischemic Stroke Wei-Chieh Weng, M.D. Department of Neurology, Chang-Gung Memorial Hospital, Kee-Lung, Taiwan Smoking related mortality Atherosclerotic vascular disease

More information

WHI Form Report of Cardiovascular Outcome Ver (For items 1-11, each question specifies mark one or mark all that apply.

WHI Form Report of Cardiovascular Outcome Ver (For items 1-11, each question specifies mark one or mark all that apply. WHI Form - Report of Cardiovascular Outcome Ver. 6. COMMENTS To be completed by Physician Adjudicator Date Completed: - - (M/D/Y) Adjudicator Code: OMB# 095-044 Exp: 4/06 -Affix label here- Clinical Center/ID:

More information

Sixth Annual Intensive Update in Neurology 9/15-16/2016. W Tom Kushner DO Swedish Stroke Clinic Neurohospitalist

Sixth Annual Intensive Update in Neurology 9/15-16/2016. W Tom Kushner DO Swedish Stroke Clinic Neurohospitalist W Tom Kushner DO Swedish Stroke Clinic Neurohospitalist 1 One Strategy for cryptogenic stroke: ESUS Positively defined criteria FDA allows clinical trials NOACs have lower risk profile Another strategy

More information

Cerebrovascular Disease. RTC Conference Resident Presenter: Dr. Christina Bailey Faculty: Dr. Jeff Dattilo October 2, 2009

Cerebrovascular Disease. RTC Conference Resident Presenter: Dr. Christina Bailey Faculty: Dr. Jeff Dattilo October 2, 2009 Cerebrovascular Disease RTC Conference Resident Presenter: Dr. Christina Bailey Faculty: Dr. Jeff Dattilo October 2, 2009 Cerebrovascular Disease Stroke is the 3 rd leading cause of death and the leading

More information

Redgrave JN, Coutts SB, Schulz UG et al. Systematic review of associations between the presence of acute ischemic lesions on

Redgrave JN, Coutts SB, Schulz UG et al. Systematic review of associations between the presence of acute ischemic lesions on 6. Imaging in TIA 6.1 What type of brain imaging should be used in suspected TIA? 6.2 Which patients with suspected TIA should be referred for urgent brain imaging? Evidence Tables IMAG1: After TIA/minor

More information

Essentials of Clinical MR, 2 nd edition. 14. Ischemia and Infarction II

Essentials of Clinical MR, 2 nd edition. 14. Ischemia and Infarction II 14. Ischemia and Infarction II Lacunar infarcts are small deep parenchymal lesions involving the basal ganglia, internal capsule, thalamus, and brainstem. The vascular supply of these areas includes the

More information

MORTALITY AND MORBIDITY RISK FROM CAROTID ARTERY ATHEROSCLEROSIS. 73 year old NS right-handed male applicant for $1 Million life insurance

MORTALITY AND MORBIDITY RISK FROM CAROTID ARTERY ATHEROSCLEROSIS. 73 year old NS right-handed male applicant for $1 Million life insurance MORTALITY AND MORBIDITY RISK FROM CAROTID ARTERY ATHEROSCLEROSIS October 17, 2012 AAIM Triennial Conference, San Diego Robert Lund, MD What Is The Risk? 73 year old NS right-handed male applicant for $1

More information

Stroke Topics. Advances in the Prevention and Treatment of Stroke. Non-Contrast Head CT. Patient 1-68 yo man

Stroke Topics. Advances in the Prevention and Treatment of Stroke. Non-Contrast Head CT. Patient 1-68 yo man Stroke Topics Advances in the Prevention and Treatment of Stroke August 10, 2009 John W. Engstrom, M.D. Professor of Neurology Acute treatment options for ischemic stroke tpa, clot retraction, future directions

More information

PFO- To Close for Comfort. By: Vincent J.Caracciolo, MD FACC

PFO- To Close for Comfort. By: Vincent J.Caracciolo, MD FACC PFO- To Close for Comfort By: Vincent J.Caracciolo, MD FACC PATENT FORAMEN OVALE PFO- congenital lesion that frequently persists into adulthood ( 25-30%)- autopsy and TEE studies. PFO prevalence higher

More information

Asthma J45.20 Mild, uncomplicated J45.21 Mild, with (acute) exacerbation J45.22 Mild, with status asthmaticus

Asthma J45.20 Mild, uncomplicated J45.21 Mild, with (acute) exacerbation J45.22 Mild, with status asthmaticus A Fib & Flutter I48.0 Paroxysmal atrial fibrillation I48.1 Persistent atrial fibrillation I48.2 Chronic atrial fibrillation I48.3 Typical atrial flutter Asthma J45.20 Mild, uncomplicated J45.21 Mild, with

More information

MORTALITY AND MORBIDITY RISK FROM CAROTID ARTERY ATHEROSCLEROSIS. 73 year old NS right-handed male applicant for $1 Million Life Insurance

MORTALITY AND MORBIDITY RISK FROM CAROTID ARTERY ATHEROSCLEROSIS. 73 year old NS right-handed male applicant for $1 Million Life Insurance MORTALITY AND MORBIDITY RISK FROM CAROTID ARTERY ATHEROSCLEROSIS October 17, 2012 AAIM Triennial Conference, San Diego Robert Lund, MD What Is The Risk? 73 year old NS right-handed male applicant for $1

More information

Stroke School for Internists Part 1

Stroke School for Internists Part 1 Stroke School for Internists Part 1 November 4, 2017 Dr. Albert Jin Dr. Gurpreet Jaswal Disclosures I receive a stipend for my role as Medical Director of the Stroke Network of SEO I have no commercial

More information

Stroke 101. Maine Cardiovascular Health Summit. Eileen Hawkins, RN, MSN, CNRN Pen Bay Stroke Program Coordinator November 7, 2013

Stroke 101. Maine Cardiovascular Health Summit. Eileen Hawkins, RN, MSN, CNRN Pen Bay Stroke Program Coordinator November 7, 2013 Stroke 101 Maine Cardiovascular Health Summit Eileen Hawkins, RN, MSN, CNRN Pen Bay Stroke Program Coordinator November 7, 2013 Stroke Statistics Definition of stroke Risk factors Warning signs Treatment

More information

EAE RECOMMENDATIONS FOR TRANSESOPHAGEAL ECHO. Cardiac Sources of Embolism. Luigi P. Badano, MD, FESC

EAE RECOMMENDATIONS FOR TRANSESOPHAGEAL ECHO. Cardiac Sources of Embolism. Luigi P. Badano, MD, FESC EAE RECOMMENDATIONS FOR TRANSESOPHAGEAL ECHO. Cardiac Sources of Embolism Luigi P. Badano, MD, FESC Background Stroke is the 3 cause of death in several industrial countries; Embolism accounts for 15-30%

More information

Unclogging The Pipes. Zahraa Rabeeah MD Chief Resident February 9,2018

Unclogging The Pipes. Zahraa Rabeeah MD Chief Resident February 9,2018 Unclogging The Pipes Zahraa Rabeeah MD Chief Resident February 9,2018 Please join Polleverywhere by texting: ZRABEEAH894 to 37607 Disclosures None Objectives Delineate the differences between TPA vs thrombectomy

More information

Stroke Case Studies. Dr Stuti Joshi Neurology Advanced Trainee Telestroke fellow

Stroke Case Studies. Dr Stuti Joshi Neurology Advanced Trainee Telestroke fellow Stroke Case Studies Dr Stuti Joshi Neurology Advanced Trainee Telestroke fellow Case 1 64 year old female with dysphasia and right arm weakness 3 hours prior CT head: dense M1 sign. No established ischaemia

More information

GERIATRICS CASE PRESENTATION

GERIATRICS CASE PRESENTATION GERIATRICS CASE PRESENTATION CASE 79 year old Patient X was admitted to hospital with SOB. He had a hx of sarcoidosis and asbestosis. Home oxygen requirement is 3-3.5litre. He was admitted, given ceftriaxone

More information

Dr Ben Turner. Consultant Neurologist and Honorary Senior Lecturer Barts and The London NHS Trust London Bridge Hospital

Dr Ben Turner. Consultant Neurologist and Honorary Senior Lecturer Barts and The London NHS Trust London Bridge Hospital Stroke Management Dr Ben Turner Consultant Neurologist and Honorary Senior Lecturer Barts and The London NHS Trust London Bridge Hospital Introduction Stroke is the major cause of disability in the developed

More information

THE FRAMINGHAM STUDY Protocol for data set vr_soe_2009_m_0522 CRITERIA FOR EVENTS. 1. Cardiovascular Disease

THE FRAMINGHAM STUDY Protocol for data set vr_soe_2009_m_0522 CRITERIA FOR EVENTS. 1. Cardiovascular Disease THE FRAMINGHAM STUDY Protocol for data set vr_soe_2009_m_0522 CRITERIA FOR EVENTS 1. Cardiovascular Disease Cardiovascular disease is considered to have developed if there was a definite manifestation

More information

III./ Cerebral embolism

III./ Cerebral embolism III./11.3 Neurological consequences of cardiac disorders Epidemiology Cardiovascular disorders are the leading cause of death in Western countries, thus the prevention, pathology and treatment of these

More information

Process Measure: Screening for Adult Obstructive Sleep Apnea

Process Measure: Screening for Adult Obstructive Sleep Apnea Process Measure: Screening for Adult Obstructive Sleep Apnea Measure Description Description Type of Measure All patients aged 18 years and older at high risk for obstructive sleep apnea (OSA) with documentation

More information

2018 Update in Diagnosis and Management of Stroke

2018 Update in Diagnosis and Management of Stroke 2018 Update in Diagnosis and Management of Stroke S. Andrew Josephson MD Carmen Castro Franceschi and Gladyne K. Mitchell Neurohospitalist Distinguished Professor Chair, Department of Neurology Director,

More information

Learning Objectives for Rotations in Vascular Surgery Year 3 Basic Clerkship

Learning Objectives for Rotations in Vascular Surgery Year 3 Basic Clerkship Learning Objectives for Rotations in Vascular Surgery Year 3 Basic Clerkship CLINICAL PROBLEMS IN VASCULAR SURGERY 1. ABDOMINAL AORTIC ANEURYSM A 70 year old man presents in the emergency department with

More information

CMS Limitations Guide - Radiology Services

CMS Limitations Guide - Radiology Services CMS Limitations Guide - Radiology Services Starting October 1, 2015, CMS will update their existing medical necessity limitations on tests and procedures to correspond to ICD-10 codes. This limitations

More information

Comorbidity or medical history Existing diagnoses between 1 January 2007 and 31 December 2011 AF management care AF symptoms Tachycardia

Comorbidity or medical history Existing diagnoses between 1 January 2007 and 31 December 2011 AF management care AF symptoms Tachycardia Supplementary Table S1 International Classification of Disease 10 (ICD-10) codes Comorbidity or medical history Existing diagnoses between 1 January 2007 and 31 December 2011 AF management care I48 AF

More information

CAROTID DEBATE High-Grade Asymptomatic Disease Should Be Repaired Selectively; Medical Management is NOT Enough

CAROTID DEBATE High-Grade Asymptomatic Disease Should Be Repaired Selectively; Medical Management is NOT Enough Todd W GenslerMD April 28, 2018 CAROTID DEBATE High-Grade Asymptomatic Disease Should Be Repaired Selectively; Medical Management is NOT Enough DISCLOSURES I have no financial disclosures Presenter name

More information

Brain Attack. Strategies in the Management of Acute Ischemic Stroke: Neuroscience Clerkship. Case Medical Center

Brain Attack. Strategies in the Management of Acute Ischemic Stroke: Neuroscience Clerkship. Case Medical Center Brain Attack Strategies in the Management of Acute Ischemic Stroke: Neuroscience Clerkship Stroke is a common and devastating disorder Third leading antecedent of death in American men, and second among

More information

NON-ATHEROSCLEROTIC PATHOLOGY OF THE CAROTID ARTERIES

NON-ATHEROSCLEROTIC PATHOLOGY OF THE CAROTID ARTERIES NON-ATHEROSCLEROTIC PATHOLOGY OF THE CAROTID ARTERIES Leslie M. Scoutt, MD, FACR Professor of Diagnostic Radiology & Surgery Vice Chair, Dept of Radiology & Biomedical Imaging Chief, Ultrasound Section

More information

Blood Supply. Allen Chung, class of 2013

Blood Supply. Allen Chung, class of 2013 Blood Supply Allen Chung, class of 2013 Objectives Understand the importance of the cerebral circulation. Understand stroke and the types of vascular problems that cause it. Understand ischemic penumbra

More information

Heart disease remains the leading cause of morbidity and mortality in industrialized nations. It accounts for nearly 40% of all deaths in the United

Heart disease remains the leading cause of morbidity and mortality in industrialized nations. It accounts for nearly 40% of all deaths in the United Heart disease remains the leading cause of morbidity and mortality in industrialized nations. It accounts for nearly 40% of all deaths in the United States, totaling about 750,000 individuals annually

More information

Raluca Pavaloiu et al. - Clinical, Epidemiological and Etiopathogenic Study of Ischemic Stroke

Raluca Pavaloiu et al. - Clinical, Epidemiological and Etiopathogenic Study of Ischemic Stroke Original Paper Clinical, Epidemiological and Etiopathogenic Study of Ischemic Stroke RALUCA PAVALOIU 1, L. MOGOANTA 2 1 Department of Neurology, Hospital of Neuropsychiatry Craiova, Romania 2 Department

More information

2015 Update in Diagnosis and Management of Stroke

2015 Update in Diagnosis and Management of Stroke 2015 Update in Diagnosis and Management of Stroke S. Andrew Josephson MD Carmen Castro Franceschi and Gladyne K. Mitchell Neurohospitalist Distinguished Professor Senior Executive Vice Chair, Department

More information

CVA. Alison Atwater PA-C

CVA. Alison Atwater PA-C CVA Alison Atwater PA-C Types of CVAs Ischemic strokes 80% of strokes 2/3 are thrombotic 1/3 are embolic emboli from the heart or arteries feeding the brain such as carotids, vertebral and basilar etc

More information

Speakers. 2015, American Heart Association 1

Speakers. 2015, American Heart Association 1 Speakers Lee Schwamm, MD, FAHA Executive Vice Chairman of Neurology, Massachusetts General Hospital Director, Stroke Service and Medical Director, MGH TeleHealth, Massachusetts General Hospital Director,

More information

Brain Attacks and Acute Stroke Management

Brain Attacks and Acute Stroke Management Brain Attacks and Acute Stroke Management WWW.RN.ORG Reviewed January, 2017, Expires January, 2019 Provider Information and Specifics available on our Website Unauthorized Distribution Prohibited 2017

More information

Direct oral anticoagulants for Embolic Strokes of Undetermined Source? George Ntaios University of Thessaly, Larissa/Greece

Direct oral anticoagulants for Embolic Strokes of Undetermined Source? George Ntaios University of Thessaly, Larissa/Greece Direct oral anticoagulants for Embolic Strokes of Undetermined Source? George Ntaios University of Thessaly, Larissa/Greece Disclosures Scholarships: European Stroke Organization; Hellenic Society of Atherosclerosis.

More information

True cryptogenic stroke

True cryptogenic stroke True cryptogenic stroke Arne Lindgren, MD, PhD Dept of Clinical Sciences Lund, Neurology, Lund University Dept of Neurology and Rehabilitation Medicine Skåne University Hospital Lund, Sweden Disclosures

More information

The Epidemiology of Stroke and Vascular Risk Factors in Cognitive Aging

The Epidemiology of Stroke and Vascular Risk Factors in Cognitive Aging The Epidemiology of Stroke and Vascular Risk Factors in Cognitive Aging REBECCA F. GOTTESMAN, MD PHD ASSOCIATE PROFESSOR OF NEUROLOGY AND EPIDEMIOLOGY JOHNS HOPKINS UNIVERSITY OCTOBER 20, 2014 Outline

More information

Ischemic stroke: management, prevention and follow up. Amit Kansara MD Providence Stroke Center Providence Brain and Spine Institute

Ischemic stroke: management, prevention and follow up. Amit Kansara MD Providence Stroke Center Providence Brain and Spine Institute Ischemic stroke: management, prevention and follow up Amit Kansara MD Providence Stroke Center Providence Brain and Spine Institute Quotes Benjamin Franklin: All would live long, but none would be old.

More information

Carotid Embolectomy and Endarterectomy for Symptomatic Complete Occlusion of the Carotid Artery as a Rescue Therapy in Acute Ischemic Stroke

Carotid Embolectomy and Endarterectomy for Symptomatic Complete Occlusion of the Carotid Artery as a Rescue Therapy in Acute Ischemic Stroke This is an Open Access article licensed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivs 3.0 License (www.karger.com/oa-license), applicable to the online version of the article

More information

Nicolas Bianchi M.D. May 15th, 2012

Nicolas Bianchi M.D. May 15th, 2012 Nicolas Bianchi M.D. May 15th, 2012 New concepts in TIA Differential Diagnosis Stroke Syndromes To learn the new definitions and concepts on TIA as a condition of high risk for stroke. To recognize the

More information

Qualifying and Outcome Strokes in the RESPECT PFO Trial: Additional Evidence of Treatment Effect

Qualifying and Outcome Strokes in the RESPECT PFO Trial: Additional Evidence of Treatment Effect Qualifying and Outcome Strokes in the RESPECT PFO Trial: Additional Evidence of Treatment Effect JEFFREY L. SAVER, MD DAVID E. THALER, MD, PHD, RICHARD W. SMALLING, MD, PHD, JOHN D. CARROLL, MD, SCOTT

More information

Vivek R. Deshmukh, MD Director, Cerebrovascular and Endovascular Neurosurgery Chairman, Department of Neurosurgery Providence Brain and Spine

Vivek R. Deshmukh, MD Director, Cerebrovascular and Endovascular Neurosurgery Chairman, Department of Neurosurgery Providence Brain and Spine Vivek R. Deshmukh, MD Director, Cerebrovascular and Endovascular Neurosurgery Chairman, Department of Neurosurgery Providence Brain and Spine Institute The Oregon Clinic Disclosure I declare that neither

More information

Why Should We Treat PFO?

Why Should We Treat PFO? Why Should We Treat PFO? SCAI Interventional Cardiology Fellows Course December 7, 2012 Jonathan Tobis, MD Director of Interventional Cardiology UCLA Disclosures Jonathan Tobis, MD 1. A Principal Investigator

More information

Modena, 6 novembre Heart and Brain. Paolo Bovi

Modena, 6 novembre Heart and Brain. Paolo Bovi MODENA STROKE CONGRESS 2014 Modena, 6 novembre 2014 Heart and Brain Paolo Bovi Stroke Unit UO Neurologia A DAI di Neuroscienze Azienda Ospedaliera Universitaria Integrata Verona I do not say so, but at

More information

TIA AND STROKE. Topics/Order of the day 1. Topics/Order of the day 2 01/08/2012

TIA AND STROKE. Topics/Order of the day 1. Topics/Order of the day 2 01/08/2012 Charles Ashton Medical Director TIA AND STROKE Topics/Order of the day 1 What Works? Clinical features of TIA inc the difference between Carotid and Vertebral territories When is a TIA not a TIA TIA management

More information

Stroke Update. Lacunar 19% Thromboembolic 6% SAH 13% ICH 13% Unknown 32% Hemorrhagic 26% Ischemic 71% Other 3% Cardioembolic 14%

Stroke Update. Lacunar 19% Thromboembolic 6% SAH 13% ICH 13% Unknown 32% Hemorrhagic 26% Ischemic 71% Other 3% Cardioembolic 14% Stroke Update Michel Torbey, MD, MPH, FAHA, FNCS Medical Director, Neurovascular Stroke Center Professor Department of Neurology and Neurosurgery The Ohio State University Wexner Medical Center Objectives

More information

Secondary Stroke Prevention: A Precautionary Tale

Secondary Stroke Prevention: A Precautionary Tale Secondary Stroke Prevention: A Precautionary Tale Kirsten George-Phillips, BSP Clinical Practice Leader, AHS Clinical Pharmacist, AHS Owen Stroke Prevention Clinic Learning Objectives! Examine literature

More information

An Introduc+on to Stroke

An Introduc+on to Stroke An Introduc+on to Stroke Elizabeth Huntoon MS, MD Assistant Professor Department of Physical Medicine and Rehabilita>on Vanderbilt University School of Medicine Defini+on Sudden focal neurologic deficit

More information

Management of intracranial atherosclerotic stenosis (ICAS)/intracranial atherosclerosis

Management of intracranial atherosclerotic stenosis (ICAS)/intracranial atherosclerosis Management of intracranial atherosclerotic stenosis (ICAS)/intracranial atherosclerosis Tim Mikesell, D.O. Oct 22, 2016 Stroke facts Despite progress in decreasing stroke incidence and mortality, stroke

More information

The Importance of Middle Cerebral Artery Stenosis In Patients With A Lacunar Infarction In The Carotid Artery Territory

The Importance of Middle Cerebral Artery Stenosis In Patients With A Lacunar Infarction In The Carotid Artery Territory The Importance of Middle Cerebral Artery Stenosis In Patients With A Lacunar Infarction In The Carotid Artery Territory Oh Young Bang, M.D., Jeong Hoon Cho, M.D., Ji Hoe Heo, M.D., Dong Ik Kim, M.D.* Department

More information

Carotid Endarterectomy for Symptomatic Complete Occlusion of the Internal Carotid Artery

Carotid Endarterectomy for Symptomatic Complete Occlusion of the Internal Carotid Artery 2011 65 4 239 245 Carotid Endarterectomy for Symptomatic Complete Occlusion of the Internal Carotid Artery a* a b a a a b 240 65 4 2011 241 9 1 60 10 2 62 17 3 67 2 4 64 7 5 69 5 6 71 1 7 55 13 8 73 1

More information

Index. cardiology.theclinics.com. Note: Page numbers of article titles are in boldface type.

Index. cardiology.theclinics.com. Note: Page numbers of article titles are in boldface type. Index Note: Page numbers of article titles are in boldface type. A Acute ischemic stroke TOAST classification of, 270 Acute myocardial infarction (AMI) cardioembolic stroke following, 207 208 noncardioembolic

More information

UvA-DARE (Digital Academic Repository) Cerebral autoregulation: from minutes to seconds Immink, R.V. Link to publication

UvA-DARE (Digital Academic Repository) Cerebral autoregulation: from minutes to seconds Immink, R.V. Link to publication UvA-DARE (Digital Academic Repository) Cerebral autoregulation: from minutes to seconds Immink, R.V. Link to publication Citation for published version (APA): Immink, R. V. (2013). Cerebral autoregulation:

More information

Karl Meisel, MD MA Director of Stroke Clinic University of California San Francisco

Karl Meisel, MD MA Director of Stroke Clinic University of California San Francisco Karl Meisel, MD MA Director of Stroke Clinic University of California San Francisco I have no financial disclosures 1 Hospital Management Thrombolytic and Thrombectomy Blood pressure Stroke in the Young

More information

Imaging of the 3 Ps in Stroke An introduction of stroke diagnostics for the non-neurologist

Imaging of the 3 Ps in Stroke An introduction of stroke diagnostics for the non-neurologist A picture is worth 1000 words but what do they mean? Imaging of the 3 Ps in Stroke An introduction of stroke diagnostics for the non-neurologist Sharon Jaspers Thunder Bay Regional Health Sciences Centre

More information

Echocardiography as a diagnostic and management tool in medical emergencies

Echocardiography as a diagnostic and management tool in medical emergencies Echocardiography as a diagnostic and management tool in medical emergencies Frank van der Heusen MD Department of Anesthesia and perioperative Care UCSF Medical Center Objective of this presentation Indications

More information

Subtyping of Ischemic Stroke Based on Vascular Imaging: Analysis of 1,167 Acute, Consecutive Patients

Subtyping of Ischemic Stroke Based on Vascular Imaging: Analysis of 1,167 Acute, Consecutive Patients Journal of Clinical Neurology / Volume 2 / December, 26 Original Articles Subtyping of Ischemic Stroke Based on Vascular Imaging: Analysis of 1,167 Acute, Consecutive Patients Jin T. Kim, M.D., Sung H.

More information

Carotid Artery Disease and What s Pertinent JOSEPH A PAULISIN DO

Carotid Artery Disease and What s Pertinent JOSEPH A PAULISIN DO Carotid Artery Disease and What s Pertinent JOSEPH A PAULISIN DO Goal of treatment of carotid disease Identify those at risk of developing symptoms Prevent patients at risk from developing symptoms Prevent

More information

Current Clinical Trials for Stroke Survivors in NJ and Philadelphia Areas

Current Clinical Trials for Stroke Survivors in NJ and Philadelphia Areas Current Clinical Trials for Survivors in NJ and Philadelphia Areas For more information go to https://clinicaltrials.gov/ and search for the title in search box Condition / Disease 1. Spatial Neglect and

More information

7. Echocardiography Appropriate Use Criteria (by Indication)

7. Echocardiography Appropriate Use Criteria (by Indication) Criteria for Echocardiography 1133 7. Echocardiography Criteria (by ) Table 1. TTE for General Evaluation of Cardiac Structure and Function Suspected Cardiac Etiology General With TTE 1. Symptoms or conditions

More information

Cryptogenic Stroke: The role of silent Atrial Fibrillation

Cryptogenic Stroke: The role of silent Atrial Fibrillation Cryptogenic Stroke: The role of silent Atrial Fibrillation PD Dr. med. Martin A. Ritter Westfälische Wilhelms-Universität Münster Germany ritterm@uni-muenster.de 1 Turin, 25.10.2014 Agenda 1. What is a

More information

DISCLOSURE TEST YOUR WAVEFORM IQ. Partial volume artifact. 86 yo female with right arm swelling, picc line. AVF on left? Dx?

DISCLOSURE TEST YOUR WAVEFORM IQ. Partial volume artifact. 86 yo female with right arm swelling, picc line. AVF on left? Dx? Deborah Rubens University of Rochester Rochester, NY DISCLOSURE Neither I nor my immediate family have a financial relationship with a commercial organization that may have a direct or indirect interest

More information

Pathology of pulmonary vascular disease. Dr.Ashraf Abdelfatah Deyab. Assistant Professor of Pathology Faculty of Medicine Almajma ah University

Pathology of pulmonary vascular disease. Dr.Ashraf Abdelfatah Deyab. Assistant Professor of Pathology Faculty of Medicine Almajma ah University Pathology of pulmonary vascular disease Dr.Ashraf Abdelfatah Deyab Assistant Professor of Pathology Faculty of Medicine Almajma ah University Pulmonary vascular disease Type of pulmonary circulation: Types

More information

Alan Barber. Professor of Clinical Neurology University of Auckland

Alan Barber. Professor of Clinical Neurology University of Auckland Alan Barber Professor of Clinical Neurology University of Auckland Presented with Non-fluent dysphasia R facial weakness Background Ischaemic heart disease Hypertension Hyperlipidemia L MCA branch

More information